It has been suggested that people with T2D have a compromised cortical bone structure expressed as a higher cortical porosity, making these results even more challenging to interpret.(101, 102) Human trials that include people exposed to GLP‐1 RAs have suggested that GLP‐1 may prevent an otherwise expected decrease in hip BMD during significant weight loss. This evidence concerns the gene GCG and type 2 diabetes mellitus.